Inverse dC (Bz) CNA CPG
CPG for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG for the incorporation of an amino function at the 3' end of an oligonucleotide.
CPG for the incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG used to incorporate a 5-methyl-modified deoxycytidine into the 3' end of an oligonucleotide.
Dideoxynucleoside CPG used in nuclease blocking.
CPG useful for synthesising 2'-5' linked oligonucleotides, and effecting 3' termination.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |